Metraipolis › archive › dc_8d833657ed32
An antibody-PROTAC conjugate targets BRD4/c-Myc/PD-L1 to enhance immunotherapy efficacy in triple-negative breast cancer — Europe PMC PMID:42526440
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42526440
- DOI
- 10.1016/j.xcrm.2026.102948
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T10:50:26.471Z
- SHA-256 of the archived text
b0164a90cf89d86a054249746db2fbe73494f26c3b674a4bdbb38f6bbeb68543- Stable URL of this page
https://metraipolis.com/documento/dc_8d833657ed32
How to cite
An antibody-PROTAC conjugate targets BRD4/c-Myc/PD-L1 to enhance immunotherapy efficacy in triple-negative breast cancer — Europe PMC PMID:42526440 — Europe PMC (en), https://europepmc.org/article/MED/42526440 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8d833657ed32 (Metraipolis archive dc_8d833657ed32, sha256 b0164a90cf89d86a054249746db2fbe73494f26c3b674a4bdbb38f6bbeb68543)
BibTeX
@misc{dc8d833657ed32,
title = {An antibody-PROTAC conjugate targets BRD4/c-Myc/PD-L1 to enhance immunotherapy efficacy in triple-negative breast cancer — Europe PMC PMID:42526440},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42526440},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8d833657ed32; sha256 b0164a90cf89d86a054249746db2fbe73494f26c3b674a4bdbb38f6bbeb68543},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42526440. Agents can read the archived copy with the MCP tool read_document.